Carol Schafer, VP Finance - Communications at Lexicon Pharmaceuticals, holds 1.00K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 59.66K shares in Aceragen (Ticker: ACGN), holds ― shares in Five Prime Therapeutics (Ticker: FPRX). Most recently, Carol Schafer ― shares of Lexicon Pharmaceuticals on ― for an estimated value of ―.
Carol Schafer latest transaction was an Uninformative Buy of ―.
What was Carol Schafer's most profitable transaction?
Carol Schafer’s most profitable transaction was an Informative Buy of RPTX stock on June 25, 2020. The return on the trade was 2.70%.
What is Carol Schafer's role in Lexicon Pharmaceuticals?
Carol Schafer's role in Lexicon Pharmaceuticals is VP Finance - Communications.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.